Health Care·Health Care Equipment·$17.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.81 | N/A | +3.19% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.81 | N/A | +3.19% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about external factors impacting performance. They emphasized their commitment to long-term growth strategies.
Management highlighted ongoing challenges in the supply chain.
They noted a focus on innovation and product development despite market pressures.
Zimmer Biomet's earnings report shows a positive surprise in EPS, but the stock fell by 7.39% following the announcement. The decline may be attributed to concerns over supply chain issues and the lack of revenue data. Investors might be cautious as the company navigates these challenges without updated guidance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Nov 1, 2021